Dalfampridine improves cognition impairment in multiple sclerosis (MS): results from a randomised, double-blind, placebo-controlled trial

Autor: De Giglio, L, De Luca, F, Gurreri, F, Ferrante, I., Prosperini, L., Quartuccio, M. E., Borriello, G., Gasperini, C., Pozzilli, C.
Jazyk: angličtina
Rok vydání: 2017
Databáze: OpenAIRE